Remdesivir: a review in COVID-19

HA Blair - Drugs, 2023 - Springer
Remdesivir (Veklury®), a nucleotide analogue prodrug with broad-spectrum antiviral activity,
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …

[HTML][HTML] Methanol Poisoning and Its Clinical Complications During the COVID-19 Pandemic in Iran: A Systematic Review

K Alaedini, Z Behroozi, A Souresrafil… - IJ Psychiatry and …, 2024 - brieflands.com
Background: During the COVID-19 pandemic, there was a surge in the consumption of
beverages containing methanol, as individuals have erroneously surmised that the ingestion …

[HTML][HTML] Efficacy of traditional Chinese medicine on shortening the negative conversion time of SARS-CoV-2 ribonucleic acid in patients with mild COVID-19: A …

YL Chen, M Yang, Y Tian, XX Chen, W Lu, HF Wei… - Science in One …, 2023 - Elsevier
Background The holistic view of the 'The unity of man and nature'promotes the development
and application of traditional Chinese medicine (TCM). Despite the absence of modern …

Analisis Biaya dan Luaran Klinik Terapi Remdesivir dibandingkan Favipiravir pada COVID-19 Derajat Sedang: Perspektif Provider

L Aniq, TM Andayani, D Endarti - JURNAL MANAJEMEN DAN … - journal.ugm.ac.id
The COVID-19 pandemic cases affect health and the economy and have become a burden
for the global community. Effective and specific antiviral for COVID-19 is still controversial …